- 专利标题： Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
-
申请号： US11213026申请日： 2005-08-26
-
公开(公告)号： US20060003417A1公开(公告)日： 2006-01-05
- 发明人: Clark Pan , James Whelan , Kevin Clairmont
- 申请人： Clark Pan , James Whelan , Kevin Clairmont
- 申请人地址： US CT West Haven
- 专利权人： Bayer Pharmaceuticals Corporation
- 当前专利权人： Bayer Pharmaceuticals Corporation
- 当前专利权人地址： US CT West Haven
- 主分类号： A61K38/17
- IPC分类号： A61K38/17 ; A61K48/00 ; C07K14/47 ; C07K16/18
摘要：
The invention provides polypeptides that act both as an agonist of the GLP-1 receptor and an antagonist of the glucagon receptor. Such polypeptides are useful for treating individuals with type 2 diabetes or other metabolic disorders.
公开/授权文献
信息查询
IPC分类:
